Tamar Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9M | Buy |
342,482
+17,027
| +5% | +$788K | 1.92% | 24 |
|
|
2025
Q1 | $19.8M | Sell |
325,455
-92,655
| -22% | -$5.65M | 2.69% | 15 |
|
|
2024
Q4 | $23.6M | Buy |
418,110
+3,950
| +1% | +$223K | 3.26% | 10 |
|
|
2024
Q3 | $21.4M | Buy |
414,160
+33,073
| +9% | +$1.71M | 3.01% | 12 |
|
|
2024
Q2 | $15.8M | Buy |
381,087
+93,685
| +33% | +$3.89M | 2.57% | 14 |
|
|
2024
Q1 | $15.6M | Buy |
287,402
+52,993
| +23% | +$2.87M | 2.63% | 12 |
|
|
2023
Q4 | $12M | Buy |
234,409
+27,758
| +13% | +$1.42M | 2.36% | 21 |
|
|
2023
Q3 | $12M | Buy |
206,651
+32,368
| +19% | +$1.88M | 2.89% | 9 |
|
|
2023
Q2 | $11.1M | Buy |
174,283
+24,068
| +16% | +$1.54M | 2.74% | 12 |
|
|
2023
Q1 | $10.4M | Buy |
150,215
+13,665
| +10% | +$947K | 2.99% | 12 |
|
|
2022
Q4 | $9.82M | Buy |
136,550
+250
| +0.2% | +$18K | 3.12% | 12 |
|
|
2022
Q3 | $9.69M | Buy |
136,300
+27,259
| +25% | +$1.94M | 3.1% | 9 |
|
|
2022
Q2 | $8.4M | Sell |
109,041
-25,926
| -19% | -$2M | 2.76% | 15 |
|
|
2022
Q1 | $9.86M | Buy |
134,967
+3,430
| +3% | +$251K | 2.75% | 14 |
|
|
2021
Q4 | $8.2M | Sell |
131,537
-3,676
| -3% | -$229K | 2.42% | 15 |
|
|
2021
Q3 | $8M | Buy |
135,213
+9,698
| +8% | +$574K | 2.89% | 12 |
|
|
2021
Q2 | $8.39M | Buy |
125,515
+12,985
| +12% | +$868K | 3.23% | 11 |
|
|
2021
Q1 | $7.1M | Buy |
112,530
+19,357
| +21% | +$1.22M | 2.75% | 12 |
|
|
2020
Q4 | $5.78M | Buy |
93,173
+8,106
| +10% | +$503K | 3.29% | 10 |
|
|
2020
Q3 | $5.13M | Buy |
85,067
+16,303
| +24% | +$983K | 3.19% | 10 |
|
|
2020
Q2 | $4.04M | Buy |
+68,764
| New | +$4.04M | 3.22% | 11 |
|